The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells
- PMID: 3038527
- PMCID: PMC553536
- DOI: 10.1002/j.1460-2075.1987.tb02412.x
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells
Abstract
A shed form of the membrane-bound B cell activation marker, BLAST-2 (Epstein-Barr virus cell surface, CD 23) was immune-affinity purified from Epstein-Barr virus-transformed lymphoblast conditioned medium. SDS-PAGE analysis revealed a complex of two polypeptides, mol. wts 25,000 and 12,000, here termed s-BLAST-2. We show that this complex, when purified to homogeneity, can act as a growth factor for EBV-infected B lymphoblasts and normal receptor-stimulated B cell blasts. It has no effect on resting B or T cells. These data suggest that the BLAST-2 antigen has a role in autocrine B cell growth. Additionally, this complex is a co-mitogen for PHA-stimulated murine thymocytes, a property of interleukin-1.
Similar articles
-
B cell growth and differentiation factors.Methods Enzymol. 1985;116:372-9. doi: 10.1016/s0076-6879(85)16029-5. Methods Enzymol. 1985. PMID: 3937026 No abstract available.
-
BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.J Immunol. 1985 May;134(5):3007-12. J Immunol. 1985. PMID: 2984280
-
Activation and immunoregulation of human B lymphocytes.Uremia Invest. 1984-1985;8(3-4):157-66. doi: 10.3109/08860228409115838. Uremia Invest. 1984. PMID: 6085841
-
Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas.Immunol Rev. 1984 Apr;78:119-35. doi: 10.1111/j.1600-065x.1984.tb00479.x. Immunol Rev. 1984. PMID: 6234220 Review.
-
B cell growth and differentiation factors and mechanism of B cell activation.Immunol Rev. 1984 Apr;78:97-118. doi: 10.1111/j.1600-065x.1984.tb00478.x. Immunol Rev. 1984. PMID: 6234224 Review. No abstract available.
Cited by
-
Immunoregulatory functions of paf-acether. VI. Dual effect on human B cell proliferation.Lipids. 1991 Dec;26(12):1204-8. doi: 10.1007/BF02536532. Lipids. 1991. PMID: 1819706
-
Structure and expression of c-fgr protooncogene mRNA in Epstein-Barr virus converted cell lines.Br J Cancer. 1988 Dec;58(6):704-9. doi: 10.1038/bjc.1988.294. Br J Cancer. 1988. PMID: 2852026 Free PMC article.
-
Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro.J Exp Med. 2003 Dec 1;198(11):1653-63. doi: 10.1084/jem.20030646. J Exp Med. 2003. PMID: 14657218 Free PMC article.
-
Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).Clin Exp Immunol. 1993 Jan;91(1):43-9. doi: 10.1111/j.1365-2249.1993.tb03351.x. Clin Exp Immunol. 1993. PMID: 8380367 Free PMC article.
-
EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.J Virol. 1994 Sep;68(9):5375-83. doi: 10.1128/JVI.68.9.5375-5383.1994. J Virol. 1994. PMID: 8057421 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials